RxSight Inc (NASDAQ:RXST) price on Friday, December 27, fall -2.37% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $34.22.
A look at the stock’s price movement, the close in the last trading session was $35.05, moving within a range at $33.419 and $35.255. The beta value (5-Year monthly) was 1.191. Turning to its 52-week performance, $66.54 and $33.03 were the 52-week high and 52-week low respectively. Overall, RXST moved -25.71% over the past month.
RxSight Inc’s market cap currently stands at around $1.38 billion, with investors looking forward to this quarter’s earnings report slated for in January.
Analysts have a consensus estimate of 40.39M for the company’s revenue for the quarter, with a low and high estimate of 40M and 41.13M respectively. The average forecast suggests up to a 41.31% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 140.08M, representing a 57.25% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that RXST is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 5 recommend RXST as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
RXST’s current price about -12.08% and -23.24% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 31.28, while 7-day volatility ratio is 4.95% and 5.20% in the 30-day chart. Further, RxSight Inc (RXST) has a beta value of 1.13, and an average true range (ATR) of 2.05. Analysts have given the company’s stock an average 52-week price target of $66, forecast between a low of $52 and high of $110. Looking at the price targets, the low is -51.96% off current price level while to achieve the yearly target high, price needs to move -221.45%. Nonetheless, investors will most likely welcome a -92.87% jump to $66 which is the analysts’ median price.
If we refocus on RxSight Inc (NASDAQ:RXST), historical trading data shows that trading volumes averaged 0.88 over the past 10 days and 607.88K over the past 3 months. The company’s latest data on shares outstanding shows there are 40.25 million shares.
The 5.05% of RxSight Inc’s shares are in the hands of company insiders while institutional holders own 84.52% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 2.58 million on 2024-11-29, giving us a short ratio of 3.95. The data shows that as of 2024-11-29 short interest in RxSight Inc (RXST) stood at 672.0 of shares outstanding, with shares short falling to 2.74 million registered in 2024-10-31. Current price change has pushed the stock -15.13% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the RXST stock continues to rise going into the next quarter.
